Fig. 2. C'liister uriuly.yi.7 ofthe inhibitor-eridothiupepsiti complex ( u ) T h e P 3 binding site for Phe in endothiapepsin, taken from coordinates derived by Foundling et ul. (1987). ( h ) T h e cluster of Phe rings generated by the pairwise distributions in GEMINI, followed by cluster analysis, are shown.
T h e development, organization and growth of complex organisms as well as their interactions with the environment involve an intricate array of molecular recognition events. There is an increased awareness of the involvement of oligosaccharides in many of these processes. In this article, studies of oligosaccharide antigenicity, and the way these have been Abbreviations used: EGF. epidermal growth factor; IGF-11% insulin-like growth factor. interpreted with respect to oligosaccharidc function will be discussed. In addition, examples of oligosaccharides as receptor, first, as receptors and determinants of susceptibility to an exogenous infective agent and secondly. as recognition structures possibly involved in endogenous interactions, will be described. This will be followed by a discussion of the recent hypothesis in which oligosaccharides are envisaged as recognition structures and integral components o f cell growth-regulating networks. Finally, an outline of new strategies for decoding the information content in glycoprotein oligosaccharides will be given.
ltitrodirctiori
Progress in studies o f glycoprotein oligosaccharides as recognition structures depends on new detection systems 1988 and ways o f coping with the heterogeneity of these structures. each of which is the product of multiple genes coding for various glycosyltransferases. Three important developments are facilitating this work. These are the availability of monoclonal antibodies. the considerable advances and refinements in techniques o f structural analysis, and the ability now to design oligosaccharide probes.
Many of the primary references relevant to this article can be found in previous publications (Feizi. 1985 (Feizi. , 1987 Feizi & Childs, 1 YXS; 1 9 8 7~; Hounsell, 1987; Thorpe et ul., 1 988) , therefore only the more recent references will be given here.
()li~~o.stic.c.litiric/c.s (IS utitigt1ti.s Studies in this Laboratory have been focused on two types o f monoclonal antibodies, T h e first are naturally occurring autoantibodies in sera of patients with autoimmune haeniolytic disorders. and the second are hybridonia-derived monoclonal antibodies raised by our collaborators in their search for ( i ) embryonic antigens, which distinguish cells of the embryo from those of adults: (ii) developmentally regulated antigens. which change during successive s t a g y of embryogenesis and fetal development; (iii) differentiation antigens. which change as stem cells give rise to their mature progeny. and (iv) tumour-associated antigens, which distinguish malignant cells from their normal counterparts. Some o f the hybridoma antibodies were raised against antigenic determimnts on the receptor for epidermal growth factor ( E G F ) . These various antigens may be collectively termed oncodevelopmental. since the same antigens may behave ;IS embryonic antigens and tumour-associated antigens. and in certain contexts. as cell type-specific antigens.
Knowledge of the precise specificities of the natural monoclonal antibodies is crucial for understanding the pathogenesis of the autoimmune disorders. A s for the hybridoma antibodies. the great motivation for raising and characterizing these has been the hope of identifying structures with important functions in normal cell growth and differentiation, and of pinpointing disorders in the neoplastic process, a s well as having antigenic markers that may be useful in the diagnosis and therapy o f human cancer.
It turns out that many of these changing oncodcvelopmental antigens are members of the family of oligosaccharides which includes the major blood group antigens A. B and H. Many are based on linear and branched oligosaccharide backbone structures which are the i and I antigens recognized by natural monoclonal autoantibodies (anti-i and anti-I). A diverse array of oncodevelopmental antigens arise from changes in branching patterns of the backbones. and their peripheral substitions. For each cell type there is a characteristic repertoire of these antigens. One o f the greatest challenges is to decode the information content and understand the function of each o f these structures. In considering their recognition functions it should be remembered that the same antigens occur on secreted glycoprotcins. and they also occur in extracellular matrices where they show pronounced temporal and regional patterns of expression.
Changes in the distribution of oncodevelopmental ;intigens o f the blood group family are among thc most common biochemical changes known t o occur in cells and tissues during development, differentiation and oncogenesis. In studies o f oligosaccharide antigens on glycoprotcins derived from human gastric epithelium, five blood-group-related antigens have been identified that arc inappropriately expressed in the gastric carcinomas of persons who have the secretor gene. Since approximately XO'%, o f the population have the secretor gene. these antigenic markers are of potential diagnostic value in the majority of the population. However. ;I close scrutiny (by immunohistochemistryi o f the Vol. 16 gastric epithelium in patients with chronic gastric disease reveals micro-foci with oligosaccharide antigen anomalies (i.e. expressing antigens different from these predicted for secretors) in areas where the pathologist cannot see signs of overt malignancy. For obvious reasons these antigenic changes are not clinically applicable at present. However, if it can be shown that they are an early reflection of a precancerous state, then surely they are the very markers that will be required in the future when new treatment regimens will, hopefully, be available for the prevention of the onset of cancer in individuals at risk. In the meantime, these changes in antigenicity are providing important insights into the biochemical changes that occur in cancer.
Thus, an important by-product of studies of oligosaccharide recognition by monoclonal antibodies is that there is now a new generation of carbohydrate sequence-specific reagents which are very powerful tools for visualizing the distribution of specific carbohydrate structures in organized tissues, in individual cells o r on their isolated glycoproteins. and for detecting the changes that take place during normal differentiation and in disease. These antibodics are most promising as the micro-sequencing rcagents for the future. As micro-scale rcagents they are quite unrivalled and givc information that cannot be obtained even by thc most sophisticated of chemical sequencing techniques. Of course, initially, powerful methods are needed t o characterize the epitopes they recognize.
Oligosucchari(Ie.~ us receptors
T h e word receptor is used hcrc as an operational term for cell-associated recognition structures. This is to comply with usage by microbiologists and endocrinologists. The receptors may be the 'locks' (as in the case of certain protein combining sites) or 'keys' (as in the case of oligosaccharides) in the interactions in question. T h e terms lectin or lectin-like are used here for proteins with oligosaccharide sequenceKeceptor.s in host-irlfective ugetit ititeructiom. One example of oligosaccharide recognition in host-infective agent interaction is human infection with Mycoplustnu pneirmotziue. This agent is a cause of epidemic and sporadic respiratory disease in man. It adheres to erythrocytes and leucocytes in addition to the bronchial epithelium. T h e erythrocyte membrane receptors for this micro-organism are long sialo-oligosaccharide structures of I antigen type. These ohgosaccharide receptors arc the products of multiple genes (at least five) coding for various glycosyltransferases that are involved in biosynthesis of the backbone regions and their peripheral substitution with sialic acid. These receptor structures occur both on glycoproteins and glycolipids. An important principle here is that the receptor structures are not associated with a single glycoprotein. Multiple glycoproteins and glycolipids that happen to have these oligosaccharides sequences serve as macromolecular receptors for the cell adhesion protein (lectin) of this micro-organism. One can make the prediction that in different cells different biological effects will be elicited following interaction with the mycoplasma, since functionally distinct glycoproteins will be cross-linked or otherwise perturbed by its lectin.
One of the most fascinating aspects o f M . ptieirmoriiuc. infection is that patients with this infection develop a transient autoimmune hacmolytic disorder with autoantibodies dirccted at the I oligosaccharide antigen of erythrocytes, i.e. the backbone of the receptor structure. Thus this infection is an extremely good model of autoimmunity in man. Several possible mechanisms can bc envisaged. Among these, a likely mechanism is that the lipid-rich mycoplasma, whcn complexed with the host cell oligosaccharides. has an adjuvant effect and stimulates an immune response to these specific combining sites other than antibody-combinin& 7 SltCS. . ' structures. The possibility has been raised that autoanti-I'ossiblc~ rrcogriitiori stnictirres iri growtli regiiluiiori. A bodies in some chronic autoimmune disorders of unknown major carrier of Carbohydrate oncodevelopmental antigens aetiologies may be elicited by a similar mechanism, namely, of the blood group family is the glycoprotein receptor for complex-formation between yet to be identified infective EGF. The receptor is s o rich in antigens of this type that the agents and specific oligosaccharides of host-cell glyco-majority of first-generation hybridoma antibodies raised to proteins and glycolipids.
that of A431 cells were found t o be directed at oligo- ( u ) glycoproteins with like carbohydrate structures would be linked by appropriate lectins, e.g. glycoprotein A and B (network I ) and glycoprotein B with a glycolipid and with glycoprotein C (network 11). In addition, linkage of certain glycoconjugates with different carbohydrate structures could be achieved through intermediaries involving lectins of different binding specificities, e.g. glycoprotein A, with glycoprotein C via networks I and 11. In ( h ) network I would be interrupted either owing t o the absence of lectin 1 or a lack of its activity resulting from a deficiency of essential factors such as calcium ions. Networks 11 and 111 would be unaffected. In (c) both networks I and II would be unlinked due to inappropriate glycosylation of glycoproteins A and B. although the relevant lectin activities are present; the result would be an uncoupling of glycoproteins A, B and C. Lectin I is here represented as a membrane-associatcd protein which varies in activity or the amounts available, and lectins II and 111 as soluble proteins; lectin I11 has an oligosaccharide specificity distinct from the other two, and network 111 may be unaffected by conditions which disrupt networks I and 11. Lectin-sugar networks need not be confined to plasma membranes, but might operate in intracellular membranes and even in the cytosol. Among the lectins in this scheme are included the carbohydrate-binding proteins of infective agents. Symbols: saccharides. Moreover. certain of the 'anti-EGF receptor' antibodies which recognize oligosaccharide structures related to blood group A. when added t o the solubilized receptor. werc found to stimulate autophosphorylation of the receptor glycoprotein. In this respect these anti-blood group A antibodies behave as growth factor agonists. Hopefully, these observations may be important clues to the involvement of blood group antigens and related oligosaccharides in the regulation of cell growth. It is possiblc that endogenous oligosaccharide-recognizing proteins (endogenous lectins) may exert growth-regulating effects through allosteric influences on the receptor glycoprotein resulting from perturbation of the oligosaccharides. Moreover. certain oligosaccharide structures which are common t o the growth factor receptor and other glycoproteins and glycolipids of the cell surface might, through interactions with endogenous lectins. form macromolecular complexes through which the receptor glycoprotein would be linked to other extra-and intra-cellular signalling systems. By an analogy with the effects o f exogenously added plant lectins. namely the growth stiniulatory effects o n certain cell types. it is predicted that endogenous lectins may similarly mediate growth-regulating effects through their interactions with growth factor reccptors and associated glycoproteins and glycolipids. It is proposed. a s depicted in Fig. 1 , that there may exist networks based o n likc Carbohydrate structures o n glycoproteins and glycolipids linked through lectins which serve as an adjustable communication system between sets o f functionally distinct glycoproteins (including those that mediate positive or negative signals) and tune the response o f cells to various stimuli.
Highly relevant t o this hypothesis have been the recent developments with respect to the receptor for insulin-like growth factor (IGF-11). Rutter and associates (Morgan er d., 1987) reported that the predicted protein sequence for the human IGF-II receptor is s o similar to the sequence predicted by Kornfeld and associates (Lobel et NI., 1987) for a bovine carbohydrate-binding protein which recognizes 0-phosphorylated mannose residues. that the two proteins can be considered analogous. Feizi & Childs (1987h) therefore suggested that the IGF-I1 receptor may be one component of a network of growth regulators with the receptor being a bi-or multi-functional protein with a combining site for IGF-I1 and another for carbohydrate. Such a mechanism o f intracellular communication could explain for example, the IGF-II effects that seem t o be mediated by the receptors for insulin and IGF-II. and it would have an inbuilt finetuning element dependent on glycosylation. Confirmatory evidence for the bifunctional nature of the IGF-I1 receptor/ mannose-(,-phosphate receptor has now been obtained from ligand-binding studies (Roth et al., 1987; Braulke et d , 1988; Tong 1' 1 d , 1988; MacDonald et ul., 1988) . To accornmodate these recent developments an updated form of the receptor 'cross-talk' cartoon may include bi-or multi-functional glycoproteins with combining sites for growth factors. and in addition lectin-like combining sites for the oligosaccharides o f those glycoconjugates with which they communicate. These ideas should be testable in the near future.
)li~ovrc~c~litiri~I~~ probes
A natural extension o f the research in this area. therefore, is t o examine whether oligosaccharide recognition by endogenous lectins plays a part in the regulation of cell growth. One priority will be to design oligosaccharide probes as a first step in these investigations: oligosaccharide probes derived from glycoprotcins and protcoglycans or synthesized chemically.
A ma,jor problem faced in studies o f recognition of glycoprotein oligosaccharides is that glycoproteins usually contain multiple oligosaccharides with differing structures. Moreover, when oligosaccharides released from glycoproteins are used as inhibitors in binding assays, relatively large amounts are required owing to the loss of the co-operative effects of multivalence. Methods are required which enable microscale analyses of individual oligosaccharide species in mixtures released from glycoproteins. Ideally, the released oligosaccharides should be assayed in multivalent state on carrier matrices. There are now under development in this Laboratory methods that are suitable for oligosaccharides released from glycoproteins, free oligosaccharides that occur naturally, or have been synthesized chemically. These involve the conjugation of oligosaccharides to a lipid, phosphatidylethanolamine dipalmitoyl, by reductive amination. The resulting neoglycolipids (referred to here as oligosaccharide probes) can be rendered multivalent by binding to plastic or silica surfaces or by incorporating into liposomes. Oligosaccharide recognition can then be assessed by solidphase binding or by inhibition assays.
Initial assessment of such probes has been by immunochemical means. Both reducing and reduced oligosaccharides have been converted into neoglycolipids with excellent antibody binding to certain core and backbone domains of 0-linked chains or to peripheral domains of oligosaccharides substituted with fucose or sulphate. Thus there is great potential for neoglycolipids in the following areas of immunochemistry ( a ) for establishing whether antibodies to glycoproteins are directed at their carbohydrate moieties; ( h ) for identifying new oligosaccharide epitopes on glycoprotein oligosaccharides; they will be especially useful with glycoproteins having single or sparse N-linked chains which may be unreactive in the monovalent state; ( c ) for detecting and selecting for characterizing minor antigenic oligosaccharides in mixtures; ( d ) for immunosequencing with panels of well-characterized monoclonal antibodies; and ( e ) for use as immunogens. However, the greatest potential for these probes is in the broader aspects of biological chemistry, for identifying new ohgosaccharide recognition systems: endogenous lectins, and adhesins of microbial agents. Thus, roles will hopefully be found for common ohgosaccharide structures, and it will be possible to detect and decode the information content of unique or unusual oligosaccharide structures on glycoproteins and proteoglycans, and to make comparisons with natural glycolipids. Finally, there is The growth factor receptor is shown here as a bifunctional glycoprotein (B) with a combining site for the growth factor and a 'lectin-like' site for an oligosaccharide structure that occurs on a second growth-regulatory glycoprotein (A).
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